PSDV - pSivida Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.06
-0.09 (-7.83%)
At close: 4:00PM EST

1.12 +0.06 (5.66%)
After hours: 4:12PM EST

Stock chart is not supported by your current browser
Previous Close1.15
Open1.20
Bid1.07 x 600
Ask1.11 x 3500
Day's Range1.02 - 1.20
52 Week Range1.02 - 2.45
Volume1,716,669
Avg. Volume697,735
Market Cap47.972M
Beta-1.59
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETFs with exposure to pSivida Corp. : December 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube14 days ago

    ETFs with exposure to pSivida Corp. : November 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • pSivida Corp. :PSDV-US: Earnings Analysis: Q1, 2018 By the Numbers : November 29, 2017
    Capital Cube15 days ago

    pSivida Corp. :PSDV-US: Earnings Analysis: Q1, 2018 By the Numbers : November 29, 2017

    Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of pSivida Corp. – Nektar Therapeutics, Regeneron Pharmaceuticals, Inc., XOMA Corporation, Alimera Sciences, Inc., Valeant Pharmaceuticals International Inc, Merck & Co., Inc., Heron Therapeutics Inc, Abbott Laboratories and Pfizer Inc. ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of PSDV earnings conference call or presentation 7-Nov-17 1:30pm GMT

    Q1 2018 pSivida Corp Earnings Call

  • Associated Presslast month

    PSivida reports 1Q loss

    On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 15 cents. The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

  • Capital Cubelast month

    ETFs with exposure to pSivida Corp. : November 3, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • pSivida Corp. :PSDV-US: Earnings Analysis: Q4, 2017 By the Numbers : October 5, 2017
    Capital Cube2 months ago

    pSivida Corp. :PSDV-US: Earnings Analysis: Q4, 2017 By the Numbers : October 5, 2017

    Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 0.70 million, Net Earnings of USD -6.12 million. Change in operating cash flow of -2.42% compared to same period last year is about the same as change in earnings, likely no significant movement ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to pSivida Corp. : September 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • pSivida Corp. :PSDV-US: Earnings Analysis: 2017 By the Numbers : September 15, 2017
    Capital Cube3 months ago

    pSivida Corp. :PSDV-US: Earnings Analysis: 2017 By the Numbers : September 15, 2017

    Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the year ended June 30, 2017. We analyze the earnings along side the following peers of pSivida Corp. – Nektar Therapeutics, Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., XOMA Corporation, Abbott Laboratories, Merck & Co., Inc., Heron Therapeutics Inc, Pfizer Inc. and Valeant Pharmaceuticals International Inc ... Read more (Read more...)

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of PSDV earnings conference call or presentation 11-Sep-17 8:30pm GMT

    Q4 2017 pSivida Corp Earnings Call

  • Is pSivida Corp (PSDV) Undervalued?
    Simply Wall St.3 months ago

    Is pSivida Corp (PSDV) Undervalued?

    pSivida Corp (NASDAQ:PSDV), a pharmaceuticals, biotechnology and life sciences company based in United States, Check out our latest analysis for pSivida Is PSDV still cheap? Good news, investors! PSDV isRead More...

  • Thomson Reuters StreetEvents6 months ago

    Edited Transcript of PSDV earnings conference call or presentation 4-May-17 8:30pm GMT

    Q3 2017 pSivida Corp Earnings Call

  • Capital Cube7 months ago

    ETFs with exposure to pSivida Corp. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube7 months ago

    ETFs with exposure to pSivida Corp. : May 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • pSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2017 By the Numbers : May 10, 2017
    Capital Cube7 months ago

    pSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2017 By the Numbers : May 10, 2017

    Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of pSivida Corp. – Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., Abbott Laboratories, Merck & Co., Inc. and Pfizer Inc. (REGN-US, ALIM-US, ABT-US, MRK-US and PFE-US) that have also reported for ... Read more (Read more...)

  • Associated Press7 months ago

    PSivida reports 3Q loss

    The Watertown, Massachusetts-based company said it had a loss of 15 cents per share. The drug delivery technology company posted revenue of $590,000 in the period. In the final minutes of trading on Thursday, ...

  • Capital Cube8 months ago

    ETFs with exposure to pSivida Corp. : April 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube9 months ago

    ETFs with exposure to pSivida Corp. : March 30, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • pSivida Corp. :PSDV-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017
    Capital Cube9 months ago

    pSivida Corp. :PSDV-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis pSivida Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of pSivida Corp. – Nektar Therapeutics, Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., XOMA Corporation, Abbott Laboratories, Merck & Co., Inc., Heron Therapeutics Inc, Pfizer Inc. and Valeant Pharmaceuticals International Inc ... Read more (Read more...)

  • Thomson Reuters StreetEvents10 months ago

    Edited Transcript of PSDV earnings conference call or presentation 7-Feb-17 9:30pm GMT

    Q2 2017 pSivida Corp Earnings Call

  • Associated Press10 months ago

    PSivida posts 2Q loss

    On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of less than 1 cent. The drug delivery technology company posted revenue of $6 million in the period. In the final minutes ...

  • pSivida Corp. (PSDV): Here’s How It Stacks Up Versus Its Peers
    Insider Monkeylast year

    pSivida Corp. (PSDV): Here’s How It Stacks Up Versus Its Peers

    We have been waiting for this for a year and finally the third quarter ended up showing a nice bump in the performance of small-cap stocks. Both the S&P 500 and Russell 2000 were up since the end of the second quarter, but small-cap stocks outperformed the large-cap stocks by double digits. This is important […]